| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Prince Henrys Institute of Medical Research, Clayton, 3168 Victoria, Australia
Address all correspondence and requests for reprints to: Dr. David Mark Robertson, Prince Henrys Institute of Medical Research, P.O. Box 5152, Clayton 3168 Victoria, Australia.
The aim of this study was to identify and characterize binding sites for inhibin in primary cultures of ovine anterior pituitary cells. Recombinant human 31-kDa inhibin A was iodinated by an optimized lactoperoxidase procedure. Fractionation of the labeled protein by gel filtration chromatography on Sephadex G-100 in 0.1 M HCl yielded two immunoactive peak regions, the second of which was bioactive as assessed by in vitro bioassay, with a ratio of bioactivity/immunoactivity of 0.620.77 and an iodine incorporation ratio of 1.72.0 mol 125I/mol inhibin. The specific binding of purified [125I]inhibin to cultured ovine pituitary cells varied with time, temperature, and cell number. Displacement of the tracer by unlabeled inhibin, as assessed by Scatchard analysis, revealed two binding sites with average Kd values of 0.28 and 3.9 nM and with approximately 250 and 3100 binding sites/anterior pituitary cell, respectively. There was little cross-reaction between inhibin and activin A (<2%), transforming growth factor-ß (<0.2%), or follistatin (<<0.1%). Examination of cell lines that were not expected to have inhibin receptors showed that there was no specific binding of inhibin to human leukemia (Jurkat) cells, whereas the binding to human embryonic kidney (293) cells was displaced by both inhibin and activin with a similar degree of cross-reaction, which suggests binding to an activin receptor. It is concluded that inhibin-binding sites with high affinity and specificity have been identified on ovine pituitary cells, consistent with both inhibin action on the pituitary and the presence of the putative inhibin receptor.
This article has been cited by other articles:
![]() |
P. G. Farnworth, Y. Wang, R. Escalona, P. Leembruggen, G. T. Ooi, and J. K. Findlay Transforming Growth Factor-{beta} Blocks Inhibin Binding to Different Target Cell Types in a Context-Dependent Manner through Dual Mechanisms Involving Betaglycan Endocrinology, November 1, 2007; 148(11): 5355 - 5368. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Makanji, C. A. Harrison, P. G. Stanton, R. Krishna, and D. M. Robertson Inhibin A and B in Vitro Bioactivities Are Modified by Their Degree of Glycosylation and Their Affinities to Betaglycan Endocrinology, May 1, 2007; 148(5): 2309 - 2316. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G Farnworth, Y. Wang, P. Leembruggen, G. T Ooi, C. Harrison, D. M Robertson, and J. K Findlay Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins. J. Endocrinol., March 1, 2006; 188(3): 451 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Dow, D. S. Russell, and R. S. Duman Regulation of Activin mRNA and Smad2 Phosphorylation by Antidepressant Treatment in the Rat Brain: Effects in Behavioral Models J. Neurosci., May 18, 2005; 25(20): 4908 - 4916. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Wiater and W. Vale Inhibin Is an Antagonist of Bone Morphogenetic Protein Signaling J. Biol. Chem., February 28, 2003; 278(10): 7934 - 7941. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Bilezikjian, A. M. O. Leal, A. L. Blount, A. Z. Corrigan, A. V. Turnbull, and W. W. Vale Rat Anterior Pituitary Folliculostellate Cells Are Targets of Interleukin-1{beta} and a Major Source of Intrapituitary Follistatin Endocrinology, February 1, 2003; 144(2): 732 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-F. Ethier, P. G. Farnworth, J. K. Findlay, and G. T. Ooi Transforming Growth Factor-{beta} Modulates Inhibin A Bioactivity in the L{beta}T2 Gonadotrope Cell Line by Competing for Binding to Betaglycan Mol. Endocrinol., December 1, 2002; 16(12): 2754 - 2763. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Bernard, S. C. Chapman, and T. K. Woodruff Minireview: Inhibin Binding Protein (InhBP/p120), Betaglycan, and the Continuing Search for the Inhibin Receptor Mol. Endocrinol., February 1, 2002; 16(2): 207 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Plant and G. R. Marshall The Functional Significance of FSH in Spermatogenesis and the Control of Its Secretion in Male Primates Endocr. Rev., December 1, 2001; 22(6): 764 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Risbridger, J. F. Schmitt, and D. M. Robertson Activins and Inhibins in Endocrine and Other Tumors Endocr. Rev., December 1, 2001; 22(6): 836 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Burger, A. C. Dalkin, K. W. Aylor, L. J. Workman, D. J. Haisenleder, and J. C. Marshall Regulation of Gonadotropin Subunit Transcription after Ovariectomy in the Rat: Measurement of Subunit Primary Transcripts Reveals Differential Roles of GnRH and Inhibin Endocrinology, August 1, 2001; 142(8): 3435 - 3442. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Chapman and T. K. Woodruff Modulation of Activin Signal Transduction by Inhibin B and Inhibin-Binding Protein (InhBP) Mol. Endocrinol., April 1, 2001; 15(4): 668 - 679. [Abstract] [Full Text] |
||||
![]() |
C. A. Harrison, P. G. Farnworth, K. L. Chan, P. G. Stanton, G. T. Ooi, J. K. Findlay, and D. M. Robertson Identification of Specific Inhibin A-Binding Proteins on Mouse Leydig (TM3) and Sertoli (TM4) Cell Lines Endocrinology, April 1, 2001; 142(4): 1393 - 1402. [Abstract] [Full Text] |
||||
![]() |
L. M. Bilezikjian, A. Z. Corrigan, A. L. Blount, Y. Chen, and W. W. Vale Regulation and Actions of Smad7 in the Modulation of Activin, Inhibin, and Transforming Growth Factor-{{beta}} Signaling in Anterior Pituitary Cells Endocrinology, March 1, 2001; 142(3): 1065 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.J. Tilbrook, D.M. de Kretser, and I.J. Clarke Influence of the Degree of Stimulation of the Pituitary by Gonadotropin-Releasing Hormone on the Action of Inhibin and Testosterone to Suppress the Secretion of the Gonadotropins in Rams Biol Reprod, February 1, 2001; 64(2): 473 - 481. [Abstract] [Full Text] |
||||
![]() |
T. M. Pierson, Y. Wang, F. J. DeMayo, M. M. Matzuk, S. Y. Tsai, and B. W. OMalley Regulable Expression of Inhibin A in Wild-Type and Inhibin {alpha} Null Mice Mol. Endocrinol., July 1, 2000; 14(7): 1075 - 1085. [Abstract] [Full Text] |
||||
![]() |
M. M. Matzuk Editorial: In Search of Binding--Identification of Inhibin Receptors Endocrinology, July 1, 2000; 141(7): 2281 - 2284. [Full Text] [PDF] |
||||
![]() |
H. Chong, S. A. Pangas, D. J. Bernard, E. Wang, J. Gitch, W. Chen, L. B. Draper, E. T. Cox, and T. K. Woodruff Structure and Expression of a Membrane Component of the Inhibin Receptor System Endocrinology, July 1, 2000; 141(7): 2600 - 2607. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wu, H. Patel, S. Mukai, C. Melino, R. Garg, X. Ni, J. Chang, and C. Peng Activin, Inhibin, and Follistatin in Zebrafish Ovary: Expression and Role in Oocyte Maturation Biol Reprod, June 1, 2000; 62(6): 1585 - 1592. [Abstract] [Full Text] |
||||
![]() |
S. C. Riley, R. Leask, C. Balfour, J. E. Brennand, and N. P. Groome Production of inhibin forms by the fetal membranes, decidua, placenta and fetus at parturition Hum. Reprod., March 1, 2000; 15(3): 578 - 583. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |